Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

BUY
$11.78 - $17.29 $399,342 - $586,131
33,900 Added 50.0%
101,700 $1.71 Million
Q3 2023

Nov 14, 2023

SELL
$11.69 - $15.02 $369,181 - $474,346
-31,581 Reduced 31.78%
67,800 $792,000
Q4 2022

Feb 14, 2023

SELL
$12.25 - $19.5 $1.52 Million - $2.43 Million
-124,431 Reduced 55.6%
99,381 $1.85 Million
Q3 2022

Nov 14, 2022

SELL
$7.06 - $15.52 $112,839 - $248,056
-15,983 Reduced 6.67%
223,812 $2.87 Million
Q2 2022

Aug 15, 2022

SELL
$6.23 - $8.57 $175,791 - $241,819
-28,217 Reduced 10.53%
239,795 $1.68 Million
Q1 2022

May 16, 2022

BUY
$5.31 - $8.31 $474,246 - $742,182
89,312 Added 49.98%
268,012 $2.22 Million
Q3 2021

Nov 15, 2021

BUY
$4.85 - $6.04 $290,515 - $361,796
59,900 Added 50.42%
178,700 $947,000
Q2 2021

Aug 16, 2021

BUY
$4.29 - $6.05 $509,652 - $718,740
118,800 New
118,800 $683,000
Q4 2020

Feb 16, 2021

SELL
$2.97 - $3.83 $237,600 - $306,400
-80,000 Closed
0 $0
Q2 2020

Aug 11, 2020

BUY
$3.48 - $5.05 $278,400 - $404,000
80,000 New
80,000 $370,000
Q4 2019

Feb 14, 2020

SELL
$3.67 - $5.7 $202,217 - $314,070
-55,100 Closed
0 $0
Q3 2019

Oct 23, 2019

BUY
$3.89 - $7.43 $214,339 - $409,393
55,100 New
55,100 $293,000

Others Institutions Holding CPRX

About CATALYST PHARMACEUTICALS, INC.


  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.33B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Alberta Investment Management Corp Portfolio

Follow Alberta Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alberta Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Alberta Investment Management Corp with notifications on news.